Validation of a modified-composite autonomic symptom score (COMPASS-31) as an outcome measure for persistent autonomic symptoms post-concussion: an observational pilot study

Matt H. HammerleLisa H. LuLucy C. ThomasAlicia A. SwanJulia M. Treleavena Brooke Army Medical Center Brain Injury Rehabilitation Service,JBSA Fort Sam Houston,San Antonio,Texas,USAb Traumatic Brain Injury Center of Excellence,Silver Spring,Maryland,USAc Brooke Army Medical Center,JBSA,Texas,USAd General Dynamics Information Technology,Falls Church,Virginia,USAe Neck Pain and Whiplash Research Unit,School of Health and Rehabilitation Services,University of Queensland,Brisbane,Queensland,Australiaf Department of Psychology,South Texas Veterans Health Care System & The University of Texas at San Antonio,San Antonio,Texas,USA
DOI: https://doi.org/10.1080/02699052.2024.2355588
2024-05-20
Brain Injury
Abstract:Objective Persistent symptoms post-mild traumatic brain injury (mTBI) includes autonomic dysregulation (AD). The composite autonomic symptoms score, (COMPASS-31), was developed to quantify AD symptom severity in the last year, which limits clinical utility. The primary aim was to determine validity of a modified-COMPASS-31 measuring symptoms in the last month compared to the original, secondarily to compare both original and modified versions to the Neurobehavioral Symptom Inventory (NSI), and tertiarily to detect change post-treatment of the modified-COMPASS-31 compared to NSI and headache intensity (HI).
neurosciences,rehabilitation
What problem does this paper attempt to address?